Adjuvant systemic therapy: the issues of timing and sequence.
Castiglione-Gertsch
M
M
International Breast Cancer Study Group Coordinating Center, Bern, Switzerland.
Gelber
R D
RD
Goldhirsch
A
A
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal